Keystone Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Keystone Wealth Services's BMY Position: Q2 2026 in Review
Keystone Wealth Services reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q2 2026, selling an estimated $12.1K and leaving 6,410 shares worth $369K. The position accounts for 0.07% of the portfolio, ranked #234.
Keystone Wealth Services first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $562K in Q2 2022. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Keystone Wealth Services held 6,410 shares of Bristol-Myers Squibb worth $369K as of Q2 2026.
- Keystone Wealth Services sold 211 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.1K.
- Bristol-Myers Squibb made up 0.07% of Keystone Wealth Services's portfolio in Q2 2026, its #234 holding.
- Keystone Wealth Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Keystone Wealth Services's Bristol-Myers Squibb position peaked at $562K in Q2 2022.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Keystone Wealth Services's 13F filing for Q2 2026, filed 5 Aug 2026.